Balloon Introducer System Market Report 2024

This Balloon Introducer System market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The balloon introducer system market size has grown strongly in recent years. It will grow from $2.7 billion in 2023 to $2.97 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period can be attributed to enhanced supply chain management, an aging population, a growing preference for outpatient procedures, increased awareness of preventive healthcare, and the expansion of government programs focused on improving public health.

The balloon introducer system market size is expected to see rapid growth in the next few years. It will grow to $4.34 billion in 2028 at a compound annual growth rate (CAGR) of 10%. The projected growth during the forecast period can be attributed to the increasing incidence of obesity, greater patient awareness, the rising prevalence of cardiovascular diseases, and a preference for minimally invasive surgeries. Key trends expected in this period include technological advancements, increased adoption in emerging markets, integration with imaging technologies, expansion of applications, and the growing adoption of telemedicine.

The rising incidence of cardiovascular diseases is anticipated to drive the growth of the balloon introducer system market in the coming years. Cardiovascular diseases encompass conditions that affect the heart and blood vessels, such as heart attacks, strokes, and hypertension. The global increase in obesity and diabetes, along with the widespread adoption of sedentary lifestyles and poor dietary habits, has contributed to the growing prevalence of these diseases. Balloon introducer systems are vital in minimally invasive procedures to unblock blood vessels, thereby improving blood flow during cardiovascular disease treatment. For example, in June 2024, data from the American Heart Association, a US-based public health organization, indicated that with high blood pressure projected to rise from 51.2% to 61%, the number of individuals diagnosed with cardiovascular diseases is expected to grow from 128 million in 2020 to over 184 million by 2050. Thus, the increase in cardiovascular diseases is fueling the expansion of the balloon introducer system market.

Major companies in the balloon introducer system market are focusing on developing innovative medical products, such as Elation balloons, to improve medical procedures. Elation balloons are specialized devices designed to assist in minimally invasive procedures by providing controlled dilation of blood vessels or other anatomical pathways. For example, in July 2022, Merit Medical Systems Inc., a US-based medical device manufacturer, introduced the smallest and shortest version of the Elation Pulmonary Balloon Dilator to meet critical patient needs. This advanced balloon allows physicians to precisely match its diameter and length to smaller airways, featuring a multi-stage configuration of 4-5-6 mm x 1.5 cm. It also includes a kink-resistant catheter, enabling multiple insertions and dilations during a single procedure, which enhances safety by preventing over-dilation in difficult strictures. The Elation balloon improves treatment options for patients by helping restore airway patency and improving their quality of life.

In October 2023, Cordis Corporation, a US-based medical company, acquired M.A. Med Alliance SA for $1.135 billion. This acquisition is intended to strengthen Cordis' leadership in drug-eluting balloon technology by integrating the SELUTION SLR technology, thereby enhancing the treatment of coronary and peripheral artery disease and aiming to reach up to two million patients globally by 2027. MedAlliance, a Switzerland-based medical technology company, specializes in advanced drug-eluting balloons and balloon introducer systems for interventional cardiology and endovascular procedures.

Major companies operating in the balloon introducer system market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Merit Medical Systems Inc., MicroPort Scientific Corporation, Blue Sail Medical Co. Ltd., Asahi Intecc Co. Ltd., Japan Lifeline Co. Ltd., AngioDynamics Inc., OrbusNeich Medical, Biosensors International Group Ltd., Alvimedica Medical Technologies, Hexacath, Cardionovum GmbH, Concept Medical Inc, Endocor GmbH.

North America was the largest region in the balloon introducer system market in 2023. The regions covered in the balloon introducer system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the balloon introducer system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A balloon introducer system is a medical device used in interventional procedures to assist in the insertion of a balloon catheter into a patient's vascular system. This system is commonly used during procedures such as angioplasty, where a balloon catheter is deployed to widen narrowed or blocked arteries.

The primary types of products in the balloon introducer system include normal balloons, cutting and scoring balloons, drug-coated balloons, and stent balloon introducers. Normal balloons are standard devices used in angioplasty to dilate narrowed or blocked arteries. These products incorporate various technologies such as rapid exchange, over-the-wire, and fixed-wire balloon catheters, making them suitable for a wide range of applications, including coronary artery diseases, peripheral artery diseases, and neurological conditions. The end users of these devices include hospitals, ambulatory surgical centers, and catheterization laboratories.

The balloon introducer system market research report is one of a series of new reports that provides balloon introducer system market statistics, including balloon introducer system industry global market size, regional shares, competitors with a balloon introducer system market share, detailed balloon introducer system market segments, market trends and opportunities, and any further data you may need to thrive in the balloon introducer system industry. This balloon introducer system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The balloon introducer system market consists of sales of balloon introducer sheaths, balloon dilators, hemostatic valves, and guiding catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.